BioHarvest Sciences Inc.
BHST
$1.90
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.88% | -6.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.88% | -6.17% | |||
| Cost of Revenue | 8.21% | -9.66% | |||
| Gross Profit | 0.89% | -3.60% | |||
| SG&A Expenses | 8.18% | 8.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.70% | 1.51% | |||
| Operating Income | -36.70% | -63.60% | |||
| Income Before Tax | -41.16% | -14.42% | |||
| Income Tax Expenses | 13.04% | 171.88% | |||
| Earnings from Continuing Operations | -40.67% | -19.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.67% | -19.83% | |||
| EBIT | -36.70% | -63.60% | |||
| EBITDA | -43.31% | -39.90% | |||
| EPS Basic | -40.69% | -13.00% | |||
| Normalized Basic EPS | -41.06% | -7.99% | |||
| EPS Diluted | -40.69% | -13.00% | |||
| Normalized Diluted EPS | -41.06% | -7.99% | |||
| Average Basic Shares Outstanding | 0.00% | 6.02% | |||
| Average Diluted Shares Outstanding | 0.00% | 6.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||